Is Prenetics Global Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: PRE) stock is to Strong Buy PRE stock.
Out of 1 analyst, 1 (100%) are recommending PRE as a Strong Buy, 0 (0%) are recommending PRE as a Buy, 0 (0%) are recommending PRE as a Hold, 0 (0%) are recommending PRE as a Sell, and 0 (0%) are recommending PRE as a Strong Sell.
What is PRE's earnings growth forecast for 2025-2025?
(NASDAQ: PRE) Prenetics Global's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Prenetics Global's earnings in 2025 is -$49,009,409.
In 2025, PRE is forecast to generate -$25,911,354 in earnings, with the lowest earnings forecast at -$25,911,354 and the highest earnings forecast at -$25,911,354.
What is PRE's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: PRE) forecast ROE is -14.5%, which is considered weak.
What is PRE's Price Target?
According to 1 Wall Street analyst that have issued a 1 year PRE price target, the average PRE price target is $9.00, with the highest PRE stock price forecast at $9.00 and the lowest PRE stock price forecast at $9.00.
The Wall Street analyst predicted that Prenetics Global's share price could reach $9.00 by Jan 16, 2026. The average Prenetics Global stock price prediction forecasts a potential upside of 72.08% from the current PRE share price of $5.23.
What is PRE's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: PRE) Prenetics Global's current Earnings Per Share (EPS) is -$3.99. In 2025, PRE's EPS is forecast to hit -$2.12 (min: -$2.12, max: -$2.12).
What is PRE's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: PRE) forecast ROA is -10.99%, which is lower than the forecast US Diagnostics & Research industry average of 8.82%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.